Clinicopathological comparison of eccrine poroma and porocarcinoma: Ki-67 index is not a decisive factor by Anna-Stiina Meriläinen, Harri Sihto, Jorma Isola, Virve Koljonen

Get full text

Fibroblast growth factor receptor expression in hemangioblastomas: A novel therapeutic target. by Maya Puttonen, Olli Tynninen, Sami Salmikangas, Tiina Vesterinen, Harri Sihto, Tom Böhling

Get full text

Pharmacokinetic profile and in vivo anticancer efficacy of anagrelide administered subcutaneously in rodents by Kirsi Toivanen, Luna De Sutter, Agnieszka Wozniak, Karo Wyns, Nanna Merikoski, Sami Salmikangas, Jianmin Duan, Mikael Maksimow, Maria Lahtinen, Tom Böhling, Patrick Schöffski, Harri Sihto

Get full text

Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization by Vadim Le Joncour, Pauliina Filppu, Maija Hyvönen, Minna Holopainen, S Pauliina Turunen, Harri Sihto, Isabel Burghardt, Heikki Joensuu, Olli Tynninen, Juha Jääskeläinen, Michael Weller, Kaisa Lehti, Reijo Käkelä, Pirjo Laakkonen

Get full text

IGF2BP3 As a Prognostic Biomarker and Regulator of Metastasis in Merkel Cell Carcinoma by Yajie Yang, Jiwei Gao, Hao Shi, Harri Sihto, Sami Kilpinen, François Vilcot, Libuse Janská, Jakob Jeschonneck, Todor Cvetanovic, Anders Höög, Jan Siarov, John Paoli, C. Christofer Juhlin, Lisa Villabona, Catharina Larsson, Weng-Onn Lui

Get full text